Literature DB >> 22762165

5-Arylidene-4-thiazolidinone derivatives active as antidegenerative agents on human chondrocyte cultures.

Annamaria Panico1, Rosanna Maccari, Venera Cardile, Lucia Crasci, Simone Ronsisvalle, Rosaria Ottanà.   

Abstract

5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogues were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1β and for their inhibitory capability against matrix metalloproteinase- 13. Our results indicated that 5-arylidene-4-thiazolidinone derivatives 1-9 exhibit antidegenerative activity and could block multiple cartilage destruction during the osteoarthritic process. Out of the selected compounds, (5-arylidene- 2,4-dioxothiazolidin-3-yl)acetic acids 7-9 showed significant effectiveness in reducing NO release and restoring normal levels of GAGs in chondrocytes treated with IL-1β. Moreover, benzoic acids 1, 5 and 6 proved to be effective MMP-13 inhibitors and were able to restore normal levels of GAGs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22762165     DOI: 10.2174/157340613804488378

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  3 in total

1.  Development and In Vitro Evaluation of an Innovative "Dietary Flavonoid Supplement" on Osteoarthritis Process.

Authors:  Maria Rosaria Lauro; Lucia Crascí; Francesca Sansone; Venera Cardile; Anna Maria Panico; Giovanni Puglisi
Journal:  Oxid Med Cell Longev       Date:  2017-03-07       Impact factor: 6.543

Review 2.  5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.

Authors:  Danylo Kaminskyy; Anna Kryshchyshyn; Roman Lesyk
Journal:  Eur J Med Chem       Date:  2017-09-20       Impact factor: 6.514

3.  Synthesis, structure-activity relationship and binding mode analysis of 4-thiazolidinone derivatives as novel inhibitors of human dihydroorotate dehydrogenase.

Authors:  Fanxun Zeng; Tiantian Qi; Chunyan Li; Tingfang Li; Honglin Li; Shiliang Li; Lili Zhu; Xiaoyong Xu
Journal:  Medchemcomm       Date:  2017-04-26       Impact factor: 3.597

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.